Mucous Membrane Decontamination Market Trends

  • Report ID: 4189
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Mucous Membrane Decontamination Market Trends

Growth Drivers

  • Rising Number of Open Surgeries - In the United Kingdom, around 12 thousand coronary artery bypass surgeries were performed from 2019 to 2020.  While in 2020, the cases of post-open surgery complications were observed to grow by 2%.
  • Open surgeries involve cutting the skin to get a full view of the organs. It is a vital procedure where surgeons make incisions of around 10 inches using a scalpel to reach the infected part for repair. After experiencing open surgeries, a patient is observed to suffer from pulmonary embolism, hemorrhage, deep vein thrombosis, and wound infection. Hence, mucous membrane decontamination becomes useful, especially to treat wound infections. Hence, this factor is anticipated to influence the market growth positively over the forecast period.
  • Increasing Inclination of Global Population Toward Personal Hygiene - As of 2020, nearly 65% of people were observed to be utilizing basic hygiene services across the globe while nearly 2 billion people across the globe were observed to lack hygiene services such as washing hands with soaps. Such habits are projected to lead to severe skin infections.
  • Higher Prevalence of Post-Surgical Wound Infection - National Library of Medicine published a report showing that 310 million major surgeries are performed worldwide every year. Additionally, it was also noticed that around 4% of the patients get surgical site infection (SSIs). Therefore, the demand for mucous membrane decontamination emerges to treat SSIs.
  • Escalating Prevalence of Autoimmune Diseases - About 3 million people in the United Kingdom were observed to be suffering from at least one autoimmune disease. For instance, approximately 32% people in the USA suffer from obesity, nearly 20% of them have cardiovascular diseases, and type 2 diabetes mellitus has effected nearly 15% of the USA pollution.
  • Surge in the C-Section Deliveries - as of 2021, it was observed that in the United States, around 30% of the were c-sectioned while primary cesarean deliveries rate was projected to be around 20 per 100 births.

Challenges

  • Lack of Awareness of the Skin and Autoimmune Diseases
  • People across the globe are not much aware of mucous membrane decontamination if it is not facilitated by the healthcare providers. It can be further responsible for bacteriostatic effect. Owing to such lack of awareness increases the chances of occurrence of various preventable infection in patients. Hence, this factor is projected to hamper the growth of the market over the forecast period.
  • Shortage of Required Medication
  • Higher Cost Associated with Mucous Membrane Decontamination

Mucous Membrane Decontamination Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

15.4%

Base Year Market Size (2023)

USD 8.08 Billion

Forecast Year Market Size (2036)

USD 52 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4189
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of mucous membrane decontamination is evaluated at USD 9.2 Billion.

The mucous membrane decontamination market size was over USD 8.08 Billion in 2023 and is anticipated to exceed USD 52 Billion by the end of 2036, growing at over 15.4% CAGR during the forecast period i.e., between 2024-2036. Increasing inclination of global population toward personal hygiene and higher prevalence of post-surgical wound infection are the major factors driving the market growth.

North America is poised to account for majority industry share by 2036, attributed to higher prevalence of autoimmune diseases driven by presence of a developed healthcare infrastructure and growing inclination of people and clinicians toward the utilization of novel drugs.

Astellas Pharma Inc., Bausch Health Companies Inc., Genentech, Inc., Lipidor AB, Pfizer Inc., Merck & Co., Inc., Sun Pharmaceutical Industries Limited, EPI Health, LLC, Mölnlycke Health Care AB, Reckitt Benckiser Group plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample